Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR Harmony OLE
NCT03067441Phase 3Completed
- Sponsor
- Esperion Therapeutics
- Start
- Feb 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in hypercholesterolemia, atherosclerotic cardiovascular disease (ASCVD), sponsored by Esperion Therapeutics. Started Feb 2017; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemiaatherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT03067441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067441.